In this episode, we discuss why some policymakers ignore basic economic principles in crafting prescription drug pricing policies. Medicare drug price negotiation, if implemented, would reduce investment in innovation, especially in drugs for Medicare beneficiaries.

00:00 Introduction

02:05 How R&D investment decisions are made

03:35 What academic research says

05:08 Summary

We strive to translate scientific findings into plain language to answer challenging healthcare questions of our time. Our unique perspectives and insights are hard to find from other venues.

You can find our articles here: https://hotbutton.substack.com

Let us know the topics of your interest. We would love to cover them. Thank you!

The video is provided by Analytica Now, a company specializing in health analytics, economics, and policy. https://analyticanow.net

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit hotbutton.substack.com